About Biogelx
Biogelx is a Healthcare company based in Lanark (United Kingdom) founded in 2012. Peptide hydrogels and preparation protocols are supplied for cell culture. Biogelx has raised $983 thousand across 2 funding rounds from investors including University of Strathclyde, Scottish Enterprise and European Union. The company has 10 employees. Biogelx offers products and services including Healthcare Blog, Articles on Nanomedicine, and Biomaterials Posts. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology. Its legal entity is BIOGELX LIMITED.
Company details
Biogelx is a biomaterials company which supplies peptide hydrogels for cell culture. Its products include lyophilized peptide powder, plus protocols for gel preparation are patented and are currently selling in the US, Europe and Asia. It claims that its products have applications in cell research, toxicologydrug development, 3D printing and also cell therapyregenerative medicine. It also states that biogelx gels can be structured to control mesenchymal stem cell differentiation and to develop in vitro models for cancer research.
- Headquarters Lanark, United Kingdom
- Employees 10
- SectorsHealthcare
- Email••••••••
- Website biogelx.com
- Social LinkedIn X
- Legal Name Biogelx Limited
- Date of Incorporation 17 Aug, 2012
- Jurisdiction 95 HAYMARKET TERRACE, EDINBURGH
- Total Equity Funding$983K (USD)
in 2 rounds
- Latest Funding Round$275.28K (USD), Grant
Mar 2018
- InvestorsUniversity of Strathclyde
& 3 more
- Employee Count10
Products & Services of Biogelx
Biogelx offers a comprehensive portfolio of products and services, including Healthcare Blog, Articles on Nanomedicine, and Biomaterials Posts.
Platform for articles on medical technologies and innovations
In-depth coverage of advancements in nanomedicine applications
Discussions on biomaterials in regenerative medicine
Funding Insights of Biogelx
Biogelx has successfully raised a total of $983K across 2 strategic funding rounds. The most recent funding activity was a Grant round of $275.28 thousand completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $983,000
- Total Rounds 2
- Last Round Grant — $275,283
- First Round $983,000
(Jun 2015)
- Investors Count 4
All 2 funding rounds of Biogelx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2018 | $275,283 | Grant | – | – | |
| Jun 2015 | $983,000 | Seed | – | University of Strathclyde, Scottish Enterprise | – |
4 investors in total: 4 institutional.
Investors in Biogelx
Biogelx has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include University of Strathclyde, Scottish Enterprise and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investment is provided to promising Scottish entrepreneurs. | gabriel-is.com | Glasgow, Scotland | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Public university offering multiple degrees and courses across diversified streams | 1796 | strath.ac.uk | Glasgow, United Kingdom | |
Business development and leadership training programs are offered to companies. | 1991 | scottish-enterprise.com | Glasgow, United Kingdom |
Investor details for Biogelx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biogelx
1 people are tracked at Biogelx (1 in leadership); the tracked headcount is 10.
| Name | Role | Group |
|---|---|---|
Alison Clayton | CEO | Leadership |
Complete people profiles for Biogelx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Biogelx
3 dated milestones of Biogelx across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Biogelx is founded.
- Funding First funding round of $983K.
- Funding Latest funding round, Grant, of $275K.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Biogelx (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biogelx
Complete news archive for Biogelx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biogelx
Biogelx was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Biogelx is headquartered in Lanark, United Kingdom. It is registered at Lanark, South Lanarkshire, United Kingdom.
Biogelx is a funded company, having raised a total of $983K across 2 funding rounds to date. The company's 1st funding round was a Seed of $983K, raised on Jun 2015.
Biogelx has 10 employees.
Biogelx is a biomaterials company which supplies peptide hydrogels for cell culture. Its products include lyophilized peptide powder, plus protocols for gel preparation are patented and are currently selling in the US, Europe and Asia. It claims that its products have applications in cell research, toxicologydrug development, 3D printing and also cell therapyregenerative medicine. It also states that biogelx gels can be structured to control mesenchymal stem cell differentiation and to develop in vitro models for cancer research.
Biogelx offers Healthcare Blog, Articles on Nanomedicine, and Biomaterials Posts.
Biogelx has 4 investors. Key investors include University of Strathclyde, Scottish Enterprise, European Union, and Gabriel Investment Syndicate.
Biogelx operates through Biogelx Limited.